Anemia in Cancer Patients – the Role of Renal Anemia
Anemia is still highly frequent in cancer patients. Usually considered as chemotherapy-induced, it can however also be related to the cancer itself. In patients presenting with concomitant kidney disease, which can be present in as high in 25% of patients according to the literature, anemia can also be of a renal origin. The consequences on its management, especially the use of erythropoiesis stimulating agents, are important in terms of ESA dosage, rhythm of administration, and length and target of treatment.
This C-KIN Working Group aims at reviewing the literature, and provide physicians with advice on how to discriminate between the different etiologies of anemia, and handle it the optimal way.
Members of the Working Group
- Gilbert Deray – France – Nephrology
- Florian Scotté – France – Oncology
- Vincent Launay-Vacher – France – Clinical Pharmacology